Literature DB >> 3440102

Respiratory stimulant effects of adenosine in man after caffeine and enprofylline.

P Smits1, J Schouten, T Thien.   

Abstract

In a double-blind and randomized study the respiratory stimulant effect of continuous intravenous adenosine infusion was studied after previous administration of caffeine, placebo and enprofylline in 10 healthy young volunteers. After placebo, adenosine induced an increase of minute ventilation (from 6.3 to 12.5 l min-1), tidal volume (from 0.60 to 0.96 l), and breathing rate (from 11.0 to 14.8 min-1). Venous pCO2 fell and pH rose after adenosine. Caffeine significantly reduced the adenosine-induced changes of minute ventilation, tidal volume, venous pCO2 and pH, whereas no changes occurred after enprofylline. Our results suggest that adenosine stimulates respiration in man by binding with specific P1-purinoceptors, which can be blocked by caffeine, but not by enprofylline.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3440102      PMCID: PMC1386409          DOI: 10.1111/j.1365-2125.1987.tb03251.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  On the mechanism of action of theophylline and caffeine.

Authors:  B B Fredholm
Journal:  Acta Med Scand       Date:  1985

2.  Evidence for an antagonism between caffeine and adenosine in the human cardiovascular system.

Authors:  P Smits; P Boekema; R De Abreu; T Thien; A van 't Laar
Journal:  J Cardiovasc Pharmacol       Date:  1987-08       Impact factor: 3.105

Review 3.  Purinergic receptors in the heart.

Authors:  G Burnstock
Journal:  Circ Res       Date:  1980-06       Impact factor: 17.367

4.  Cardiovascular effects of adenosine.

Authors:  B B Fredholm; A Sollevi
Journal:  Clin Physiol       Date:  1986-02

5.  Adenosine in the local regulation of blood flow: a brief overview.

Authors:  R M Berne; R M Knabb; S W Ely; R Rubio
Journal:  Fed Proc       Date:  1983-12

6.  Xanthine derivatives as adenosine receptor antagonists.

Authors:  B B Fredholm; C G Persson
Journal:  Eur J Pharmacol       Date:  1982-07-30       Impact factor: 4.432

7.  Adenosine-induced respiratory stimulation in man depends on site of infusion. Evidence for an action on the carotid body?

Authors:  A H Watt; P G Reid; M R Stephens; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

8.  Increased body fluid purine levels during hypotensive events. Evidence for ATP degradation.

Authors:  J O Woolliscroft; I H Fox
Journal:  Am J Med       Date:  1986-09       Impact factor: 4.965

9.  Adenosine stimulates respiration in man.

Authors:  A H Watt; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

  9 in total
  5 in total

1.  Caffeine Enhances Heart Rate Variability in Middle-Aged Healthy, But Not Heart Failure Subjects.

Authors:  Catherine F Notarius; John S Floras
Journal:  J Caffeine Res       Date:  2012-06

2.  Effect of theophylline on periodic breathing in congestive heart failure measured by transcutaneous oxygen monitoring.

Authors:  J Tomcsányi; K Karlócai
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

3.  Plasma adenosine during investigation of hypoxic ventilatory response.

Authors:  Dirk Drumm; Markus Hoefer; Janos Juhász; Eva Huszár; Gerhard W Sybrecht
Journal:  Sleep Breath       Date:  2004-03       Impact factor: 2.816

4.  Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection.

Authors:  G A Rongen; P Smits; K Ver Donck; J J Willemsen; R A De Abreu; H Van Belle; T Thien
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

5.  Respiration-related variations in Pd/Pa ratio and fractional flow reserve in resting conditions and during intravenous adenosine administration.

Authors:  Rutger G T Feenstra; Martijn A van Lavieren; Mauro Echavarria-Pinto; Gilbert W Wijntjens; Valerie E Stegehuis; Martijn Meuwissen; Robbert J de Winter; Marcel A M Beijk; Amir Lerman; Javier Escaned; Jan J Piek; Tim P van de Hoef
Journal:  Catheter Cardiovasc Interv       Date:  2021-11-12       Impact factor: 2.585

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.